CoChat

Neurobiological Basis of Increased Risk for Suicidal Behaviour

Open access
Wisłowska-Stanek, Aleksandra, Kołosowska, Karolina, Maciejak, Piotr · 2021 · Cells
Cited by 110

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

According to the World Health Organization (WHO), more than 700,000 people die per year due to suicide. Suicide risk factors include a previous suicide attempt and psychiatric disorders. The highest mortality rate in suicide worldwide is due to depression. Current evidence suggests that suicide etiopathogenesis is associated with neuroinflammation that activates the kynurenine pathway and causes subsequent serotonin depletion and stimulation of glutamate neurotransmission. These changes are accompanied by decreased BDNF (brain-derived neurotrophic factor) levels in the brain, which is often linked to impaired neuroplasticity and cognitive deficits. Most suicidal patients have a hyperactive hypothalamus–pituitary–adrenal (HPA) axis. Epigenetic mechanisms control the above-mentioned neurobiological changes associated with suicidal behaviour. Suicide risk could be attenuated by appropriate psychological treatment, electroconvulsive treatment, and drugs: lithium, ketamine, esketamine, clozapine. In this review, we present the etiopathogenesis of suicide behaviour and explore the mechanisms of action of anti-suicidal treatments, pinpointing similarities among them.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells10102519

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 109

  1. Milner, 2012, Suicide in the absence of mental disorder? A review of psychological autopsy studies across countries, Int. J. Soc. Psychiatry, 59, 545, 10.1177/0020764012444259 · DOI · Paper page
  2. Roy, 2017, Understanding epigenetic architecture of suicide neurobiology: A critical perspective, Neurosci. Biobehav. Rev., 72, 10, 10.1016/j.neubiorev.2016.10.031 · DOI · Paper page
  3. De Berardis, D., Fornaro, M., Valchera, A., Cavuto, M., Perna, G., Di Nicola, M., Serafini, G., Carano, A., Pompili, M., and Vellante, F. (2018). Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors. Int. J. Mol. Sci., 19. · DOI · Paper page
  4. Baldessarini, 2019, Epidemiology of suicide: Recent developments, Epidemiol. Psychiatr. Sci., 29, e71, 10.1017/S2045796019000672 · DOI · Paper page
  5. Borges, 2017, A meta-analysis of acute use of alcohol and the risk of suicide attempt, Psychol. Med., 47, 949, 10.1017/S0033291716002841 · DOI · Paper page
  6. Meltzer, 2003, Serotonin receptors their key role in drugs to treat schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 1159, 10.1016/j.pnpbp.2003.09.010 · DOI · Paper page
  7. Mortensen, 2000, Psychiatric illness and risk factors for suicide in Denmark, Lancet, 355, 9, 10.1016/S0140-6736(99)06376-X · DOI · Paper page
  8. Breslau, 1992, Migraine, suicidal ideation, and suicide attempts, Neurology, 42, 392, 10.1212/WNL.42.2.392 · DOI · Paper page
  9. McFarland, 2019, Suicide in patients with cancer: Identifying the risk factors, Oncology, 33, 221
  10. Calati, 2020, Candidate biomarkers of suicide crisis syndrome: What to test next? A concept paper, Int. J. Neuropsychopharmacol., 23, 192, 10.1093/ijnp/pyz063 · DOI
  11. Martinez, 2020, Glutamine and new pharmacological targets to treat suicidal ideation, Curr. Top. Behav. Neurosci., 46, 179, 10.1007/7854_2020_168 · DOI
  12. Perroud, 2011, Impulsivity, aggression and suicidal behavior in unipolar and bipolar disorders, J. Affect. Disord., 134, 112, 10.1016/j.jad.2011.05.048 · DOI
  13. Mullins, 2019, GWAS of suicide attempt in psychiatric disorders and association with major depression polygenic risk scores, Am. J. Psychiatry., 176, 651, 10.1176/appi.ajp.2019.18080957 · DOI · Paper page
  14. Chu, 2017, The role of stressful life events preceding death by suicide: Evidence from two samples of suicide decedents, Psychiatry Res., 256, 345, 10.1016/j.psychres.2017.06.078 · DOI
  15. Dwivedi, 2018, MicroRNAs in depression and suicide: Recent insights and future perspectives, J. Affect. Disord., 240, 146, 10.1016/j.jad.2018.07.075 · DOI · Paper page
  16. Lenz, 2019, The androgen model of suicide completion, Prog. Neurobiol., 172, 84, 10.1016/j.pneurobio.2018.06.003 · DOI
  17. Killgore, 2020, Trends in suicidal ideation over the first three months of COVID-19 lockdowns, Psychiatry Res., 293, 113390, 10.1016/j.psychres.2020.113390 · DOI · Paper page
  18. Allen, 2020, MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior, Mol. Psychiatry, 25, 308, 10.1038/s41380-019-0597-8 · DOI
  19. Orsolini, 2020, Understanding the complex of suicide in depression: From research to clinics, Psychiatry Investig., 17, 207, 10.30773/pi.2019.0171 · DOI · Paper page
  20. Sueki, 2020, Relationship between beck hopelessness scale and suicidal ideation: A short-term longitudinal study, Death Stud., 17, 1
  21. Asarnow, 2012, Suicide attempt risk in youths: Utility of the harkavy-asnis suicide scale for monitoring risk levels, Suicide Life-Threat. Behav., 42, 684, 10.1111/j.1943-278X.2012.00122.x · DOI
  22. Ofek, 1998, The child suicide potential scale: Inter-rater reliability and validity in Israeli in-patient adolescents, Isr. J. Psychiatry Relat. Sci., 35, 253
  23. Miura, 2008, A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression, Stress, 11, 198, 10.1080/10253890701754068 · DOI · Paper page
  24. Pandey, 2013, Biological basis of suicide and suicidal behavior, Bipolar Disord., 15, 524, 10.1111/bdi.12089 · DOI · Paper page
  25. Niculescu, 2015, Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach, Mol. Psychiatry, 20, 1266, 10.1038/mp.2015.112 · DOI · Paper page
  26. Niculescu, 2017, Precision medicine for suicidality: From universality to subtypes and personalisation, Mol. Psychiatry., 22, 1250, 10.1038/mp.2017.128 · DOI · Paper page
  27. Lin, H.-T., Lai, C.-H., Perng, H.-J., Chung, C.-H., Wang, C.-C., Chen, W.-L., and Chien, W.-C. (2018). Insomnia as an independent predictor of suicide attempts: A nationwide population-based retrospective cohort study. BMC Psychiatry, 18. · DOI
  28. Amitai, 2020, Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth, Brain Behav. Immun., 87, 301, 10.1016/j.bbi.2019.12.017 · DOI
  29. Cha, 2017, Annual research review: Suicide among youth—epidemiology, (potential) etiology, and treatment, J. Child Psychol. Psychiatry, 59, 460, 10.1111/jcpp.12831 · DOI · Paper page
  30. Sudol, 2017, Biomarkers of sicide attempt behavior: Towards biological model of risk, Curr. Psychiatry. Rep., 19, 31, 10.1007/s11920-017-0781-y · DOI · Paper page
  31. Sockalingam, 2010, Suicide risk in hepatitis C and during interferon-alpha therapy: A review and clinical update, J. Viral Hepat., 18, 153, 10.1111/j.1365-2893.2010.01393.x · DOI · Paper page
  32. Stuart, 2014, Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies, Neurosci. Biobehav. Rev., 42, 93, 10.1016/j.neubiorev.2014.02.001 · DOI · Paper page
  33. Nassar, 2014, Effects of lithium on inflammation, ACS Chem. Neurosci., 5, 451, 10.1021/cn500038f · DOI · Paper page
  34. Lehrer, 2019, Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce suicidal ideation and depression, Discov. Med, 28, 205
  35. Lydholm, 2019, Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: Meta-analysis of clinical trials, Acta Psychiatr. Scand., 139, 404, 10.1111/acps.13016 · DOI · Paper page
  36. Fourrier, 2018, Anti-inflammatory treatment of depression: Study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo, Trials, 19, 447, 10.1186/s13063-018-2829-7 · DOI · Paper page
  37. Halaris, 2020, Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial, J. Affect. Disord., 261, 145, 10.1016/j.jad.2019.10.021 · DOI · Paper page
  38. Sas, K., Szabó, E., and Vécsei, L. (2018). Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection. Molecules, 23. · DOI · Paper page
  39. Schwieler, 2018, Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia, Neuropharmacology, 138, 130, 10.1016/j.neuropharm.2018.06.003 · DOI
  40. Savitz, 2020, The kynurenine pathway: A finger in every pie, Mol. Psychiatry, 25, 131, 10.1038/s41380-019-0414-4 · DOI · Paper page
  41. Asberg, 1976, 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?, Arch. Gen. Psychiatry., 33, 1193, 10.1001/archpsyc.1976.01770100055005 · DOI · Paper page
  42. Sher, 2006, A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder, Bipolar Disord., 8, 543, 10.1111/j.1399-5618.2006.00319.x · DOI
  43. Pandey, 2013, Region-specific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims, Psychoneuroendocrinology, 38, 2628, 10.1016/j.psyneuen.2013.06.020 · DOI
  44. Stockmeier, 1997, Serotonin receptors in suicide victims with major depression, Neuropsychopharmacology, 16, 162, 10.1016/S0893-133X(96)00170-4 · DOI
  45. Bennett, 2000, Tryptophan hydroxylase polymorphisms in suicide victims, Psychiatr. Genet., 10, 13, 10.1097/00041444-200010010-00003 · DOI
  46. Autry, 2009, Epigenetics in suicide and depression, Biol. Psychiatry, 66, 812, 10.1016/j.biopsych.2009.08.033 · DOI · Paper page
  47. Misztak, P., Pańczyszyn-Trzewik, P., Nowak, G., and Sowa-Kućma, M. (2020). Epigenetic marks and their relationship with BDNF in the brain of suicide victims. PLoS ONE, 15. · DOI
  48. 2017, Decrease in brain-derived neurotrophic factor at plasma level but not in serum concentrations in suicide behavior: A systematic review and meta-analysis, Brain Behav., 7, e00706, 10.1002/brb3.706 · DOI · Paper page
  49. Pompili, 2010, The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: A selective overview for the implications of suicide prevention, Eur. Arch. Psychiatry Clin. Neurosci., 260, 583, 10.1007/s00406-010-0108-z · DOI · Paper page
  50. Yerevanian, 2004, Antidepressants and suicidal behaviour in unipolar depression, Acta Psychiatr. Scand., 110, 452, 10.1111/j.1600-0447.2004.00437.x · DOI · Paper page
  51. Turecki, 2014, Epigenetics and suicidal behavior research pathways, Am. J. Prev. Med., 47, S144, 10.1016/j.amepre.2014.06.011 · DOI
  52. Berardelli, I., Serafini, G., Cortese, N., Fiaschè, F., O’Connor, R.C., and Pompili, M. (2020). The involvement of hypothalamus-pituitary-adrenal (HPA) axis in suicide risk. Brain Sci., 10. · DOI · Paper page
  53. Merali, 2004, Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA (A) receptor subunits in frontal cortical brain region, J. Neurosci., 24, 1478, 10.1523/JNEUROSCI.4734-03.2004 · DOI · Paper page
  54. Pandey, 2019, Increased protein and mRNA expression of corticotropin-releasing factor (CRF), decreased CRF receptors and CRF binding protein in specific postmortem brain areas of teenage suicide subjects, Psychoneuroendocrinology, 106, 233, 10.1016/j.psyneuen.2019.04.015 · DOI
  55. Gaynor, 2016, A targeted sequencing study of glutamatergic candidate genes in suicide attempters with bipolar disorder, Am. J. Med. Genet. Part B Neuropsychiatr. Genet., 171, 1080, 10.1002/ajmg.b.32479 · DOI
  56. Szewczyk, 2013, Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims, J. Affect. Disord., 151, 924, 10.1016/j.jad.2013.08.009 · DOI
  57. Kim, S., Choi, K.-H., Baykiz, A.F., and Gershenfeld, H.K. (2007). Suicide candidate genes associated with bipolar disorder and schizophrenia: An exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genom., 8. · DOI · Paper page
  58. Poulter, 2010, Altered organization of GABAA receptor mRNA expression in the depressed suicide brain, Front. Mol. Neurosci., 3, 3, 10.3389/neuro.02.003.2010 · DOI · Paper page
  59. Yin, 2020, Interactions of the GABRG2 polymorphisms and childhood trauma on suicide attempt and related traits in depressed patients, J. Affect. Disord., 266, 447, 10.1016/j.jad.2020.01.126 · DOI
  60. Soreni, 1999, Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts, Biol. Psychiatry, 46, 484, 10.1016/S0006-3223(98)00342-4 · DOI
  61. Brunner, 2001, Cholesterol, omega-3 fatty acids, and suicide risk: Empirical evidence and pathophysiological hypotheses, Fortschr. Neurol. Psychiatr., 69, 460, 10.1055/s-2001-17564 · DOI
  62. Kunugi, 1997, Low serum cholesterol in suicide attempters, Biol. Psychiatry, 41, 196, 10.1016/S0006-3223(95)00672-9 · DOI
  63. Sublette, 2020, Lipids and suicide risk, Curr. Top. Behav. Neurosci., 46, 155, 10.1007/7854_2020_163 · DOI
  64. Kim, 2004, Clinical application of low serum cholesterol as an indicator for suicide risk in major depression, J. Affect. Disord., 81, 161, 10.1016/S0165-0327(03)00166-6 · DOI
  65. Knowles, 2018, Disentangling the genetic overlap between cholesterol and suicide risk, Neuropsychopharmacology, 43, 2556, 10.1038/s41386-018-0162-1 · DOI
  66. Molero, 2020, Associations between statin use and suicidality, depression, anxiety, and seizures: A Swedish total-population cohort study, Lancet Psychiatry, 7, 982, 10.1016/S2215-0366(20)30311-4 · DOI
  67. Freemantle, 2013, Analysis of oxysterols and cholesterol in prefrontal cortex of suicides, Int. J. Neuropsychopharmacol., 16, 1241, 10.1017/S1461145712001587 · DOI · Paper page
  68. Kouter, 2019, Genome-wide DNA methylation patterns in suicide victims: Identification of new candidate genes, Psychiatr. Danub., 31, 392, 10.24869/psyd.2019.392 · DOI
  69. Squassina, 2020, MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings, Eur. Neuropsychopharmacol., 34, 39, 10.1016/j.euroneuro.2020.03.005 · DOI
  70. Roy, 2020, Exploiting circulating microRNAs as biomarkers in psychiatric disorders, Mol. Diagn. Ther., 24, 279, 10.1007/s40291-020-00464-9 · DOI · Paper page
  71. Miller, 2001, An integrative theory of prefrontal cortex function, Annu. Rev. Neurosci., 24, 167, 10.1146/annurev.neuro.24.1.167 · DOI · Paper page
  72. Lewis, 2020, Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation, Transl. Psychiatry, 10, 119, 10.1038/s41398-020-0792-z · DOI
  73. Zhu, 2020, Discriminating suicide attempters and predicting suicide risk using altered frontolimbic resting-state functional connectivity in patients with bipolar II disorder, Front. Psychiatry, 11, 597770, 10.3389/fpsyt.2020.597770 · DOI
  74. Guzzetta, 2007, Lithium treatment reduces suicide risk in recurrent major depressive disorder, J. Clin. Psychiatry, 68, 380, 10.4088/JCP.v68n0304 · DOI · Paper page
  75. King, 2018, Emerging trends in adolescent suicide prevention research, Curr. Opin. Psychol., 22, 89, 10.1016/j.copsyc.2017.08.037 · DOI
  76. Cwik, 2020, Suicide in the pediatric population: Screening, risk assessment and treatment, Int. Rev. Psychiatry, 32, 254, 10.1080/09540261.2019.1693351 · DOI
  77. Peltzman, 2020, Effects of electroconvulsive therapy on short-term suicide mortality in a risk-matched patient population, J. ECT, 36, 187, 10.1097/YCT.0000000000000665 · DOI
  78. Calaway, 2016, A systematic review of the safety of electroconvulsive therapy use during the first trimester of pregnancy, J. ECT, 32, 230, 10.1097/YCT.0000000000000330 · DOI
  79. Pompili, 2014, Electroconvulsive treatment during pregnancy: A systematic review, Expert Rev. Neurother., 14, 1377, 10.1586/14737175.2014.972373 · DOI
  80. Pinna, 2018, Clinical and biological predictors of response to electroconvulsive therapy (ECT): A review, Neurosci. Lett., 669, 32, 10.1016/j.neulet.2016.10.047 · DOI
  81. Bioque, 2019, Effects of electroconvulsive therapy in the systemic inflammatory balance of patients with severe mental disorder, Psychiatry Clin. Neurosci., 73, 628, 10.1111/pcn.12906 · DOI
  82. Benard, 2016, Lithium and suicide prevention in bipolar disorder, L’Encéphale, 42, 234, 10.1016/j.encep.2016.02.006 · DOI
  83. Smith, 2017, Lithium and suicide in mood disorders: Updated meta-review of the scientific literature, Bipolar Disord., 19, 575, 10.1111/bdi.12543 · DOI · Paper page
  84. Wada, 2009, Lithium and neuropsychiatric therapeutics: Neuroplasticity via. glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades, J. Pharmacol. Sci., 110, 14, 10.1254/jphs.09R02CR · DOI · Paper page
  85. Wilkowska, 2019, Clozapine: Promising treatment for suicidality in bipolar disorder, Psychiatr. Danub, 31, 574
  86. Tondo, 2018, Antisuicidal effects in mood disorders: Are they unique to lithium?, Pharmacopsychiatry, 51, 177, 10.1055/a-0596-7853 · DOI · Paper page
  87. Malhi, 2013, Potential mechanisms of action of lithium in bipolar disorder, CNS Drugs, 27, 135, 10.1007/s40263-013-0039-0 · DOI · Paper page
  88. Rapaport, 2001, The effects of lithium on ex vivo cytokine production, Biol. Psychiatry, 50, 217, 10.1016/S0006-3223(01)01144-1 · DOI
  89. Bosetti, 2002, Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain, Mol. Psychiatry, 7, 845, 10.1038/sj.mp.4001111 · DOI
  90. Griffiths, 2014, Existing and novel biological therapeutics in suicide prevention, Am. J. Prev. Med., 47, S195, 10.1016/j.amepre.2014.06.012 · DOI
  91. Spivak, 1998, Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine, Clin. Neuropharmacol., 21, 245
  92. Rassoulpour, 2006, Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain, J. Neural Transm., 113, 1355, 10.1007/s00702-005-0432-z · DOI
  93. Pandurangi, 2019, Inflammation, antipsychotic drugs, and evidence for effectiveness of anti-inflammatory agents in schizophrenia, Curr. Top. Behav. Neurosci., 44, 227, 10.1007/7854_2019_91 · DOI
  94. Duman, 2018, Ketamine and rapid-acting antidepressants: A new era in the battle against depression and suicide, F1000Research, 7, 659, 10.12688/f1000research.14344.1 · DOI · Paper page
  95. Ramadan, 2020, Could ketamine be the answer to treating treatment-resistant major depressive disorder?, Gen. Psychiatr., 33, e100227, 10.1136/gpsych-2020-100227 · DOI
  96. Veraart, 2021, Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review, J. Affect. Disord., 281, 82, 10.1016/j.jad.2020.11.123 · DOI
  97. Isacsson, 2014, Antidepressant drugs and the risk of suicide in children and adolescents, Pediatr. Drugs, 16, 115, 10.1007/s40272-013-0061-1 · DOI
  98. Teicher, 1993, Antidepressant drugs and the emergence of suicidal tendencies, Drug Saf., 8, 186, 10.2165/00002018-199308030-00002 · DOI · Paper page
  99. 1999, Antidepressants and suicidal risk, J. Clin. Psychiatry, 60, 94
  100. Patorno, 2010, Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death, JAMA, 303, 1401, 10.1001/jama.2010.410 · DOI · Paper page
  101. Mula, 2013, Suicide risk in people with epilepsy taking antiepileptic drugs, Bipolar Disord., 15, 622, 10.1111/bdi.12091 · DOI
  102. Fruhbauerova, 2019, Addiction counselors and suicide: Education and experience do not improve suicide knowledge, beliefs, or confidence in treating suicidal clients, J. Subst. Abus. Treat., 106, 29, 10.1016/j.jsat.2019.08.012 · DOI
  103. Lynch, 2020, Substance use disorders and risk of suicide in a general US population: A case control study, Addict. Sci. Clin. Pr., 15, 14, 10.1186/s13722-020-0181-1 · DOI · Paper page
  104. Zhornitsky, 2020, Interpersonal risk factors for suicide in cocaine dependence: Association with self-esteem, personality traits, and childhood abuse, Suicide Life-Threat. Behav., 50, 867, 10.1111/sltb.12621 · DOI
  105. Miller, 1991, Suicide risk associated with drug and alcohol dependence, J. Addict. Dis., 10, 49, 10.1300/J069v10n03_06 · DOI
  106. Arensman, E., Bennardi, M., Larkin, C., Wall, A., McAuliffe, C., McCarthy, J., Williamson, E., and Perry, I. (2016). Suicide among young people and adults in Ireland: Method characteristics, toxicological analysis and substance abuse histories compared. PLoS ONE, 11. · DOI
  107. Masferrer, L., and Caparrós, B. (2017). Risk of suicide and dysfunctional patterns of personality among bereaved substance users. Int. J. Environ. Res. Public Health, 14. · DOI
  108. Lasota, D., Al-Wathinani, A., Krajewski, P., Mirowska-Guzel, D., Goniewicz, K., Hertelendy, A.J., Alhazmi, R.A., Pawłowski, W., Khorram-Manesh, A., and Goniewicz, M. (2020). Alcohol and the risk of railway suicide. Int. J. Environ. Res. Public Health, 17. · DOI
  109. Pirkola, 2004, Suicide in alcohol-dependent individuals: Epidemiology and management, CNS Drugs., 18, 423, 10.2165/00023210-200418070-00002 · DOI

Cited by

See all 110

Metadata

Authors
Wisłowska-Stanek, A., Kołosowska, K., & Maciejak, P.
Venue
Cells
Publisher
MDPI AG
Published
2021-09-23
Volume
10
Issue
10
Pages
2519
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3202617205
Cited by
110
References
52
FWCI
8.25
Type
journal article
Language
en
Open access
gold
Funders
Narodowe Centrum Nauki (2016/21/B/NZ7/02066)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurobiological Basis of Increased Risk for Suicidal Behaviour. https://app.cochat.ai/papers/10.3390/cells10102519
The paper
Wisłowska-Stanek, A., Kołosowska, K., & Maciejak, P. (2021). Neurobiological Basis of Increased Risk for Suicidal Behaviour. Cells. https://doi.org/10.3390/cells10102519

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.